Clinical research in Taiwan


Taiwan is the world’s fifteenth most densely inhabited nation and home to a growing biotech industry. The CRO market in Taiwan is driven by pre-clinical and clinical CROs, bioequivalence studies and clinical laboratory business. This chapter describes the evolution of GCP, the clinical trial processes and key pharmaceutical players undertaking clinical research in Taiwan. Finally, it provides an environmental analysis, highlighting opportunities and challenges for the CRO industry.

6.1 Pharmaceutical industry overview

Taiwan is the world’s fifteenth most densely inhabited nation, with a population density of 635 people per square kilometre. In 2009, the estimated population of Taiwan was over 23 million. ...

Get Clinical Research in Asia now with O’Reilly online learning.

O’Reilly members experience live online training, plus books, videos, and digital content from 200+ publishers.